Attention AACR Annual Meeting 2018 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 35 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 32 33 34 35 presentations: 1 to 25 of 866
Next generation humanized mice in cancer research
Leonard D Shultz
The Jackson Laboratory Cancer Ctr., Bar Harbor, ME, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Targeting the innate immune response in models of leukemia and lymphoma
David M Weinstock
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Understanding clonal complexity of human hematologic malignancies by single-cell genomics and PDX modeling
Fumihiko Ishikawa
RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Integrated Genomics for PDX
Carol J Bult
The Jackson Laboratory, Bar Harbor, ME, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Trial designs for targeted cancer therapies: The case for being inclusive
Tatiana Prowell
U.S. Food and Drug Administration and Johns Hopkins Kimmel Cancer Center, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Trial designs for targeted cancer therapies:Tackling primary and secondary resistance
Keith Thomas Flaherty
Massachusetts General Hosp. Cancer Ctr., Boston, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Incorporation of circulating biomarkers in targeted cancer therapy trials
Lecia V Sequist
Massachusetts General Hosp. Cancer Ctr., Boston, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Understanding and targeting RNA splicing factor mutations in cancer
Omar Abdel-Wahab
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
The functional impact of alternative splicing in cancer
Eduardo Eyras
Pompeu Fabra University, Barcelona, Spain
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Targeting RNA post-transcriptional processing by inhibition of protein arginine methyltrasnferases
Ernesto Guccione
Icahn School of Medicine at Mount Sinai, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
From genetics to cancer therapeutics: New frontiers in the RNAworld
Thomas F Westbrook
Baylor College of Medicine, Houston, TX, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Targeting CDKs in thetreatment of breast cancer
Nicholas C Turner
Royal Marsden Hospital Inst. of Cancer Res., London, United Kingdom
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Identifying clinical biomarkers for CDK4/6 inhibitors
Fabrice Andre
Institut Gustave Roussy, Villejuif, France
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Biologic mechanisms underlying the sensitivity of ER+ cancers to CDK4/6i
Sarat Chandarlapaty
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Mechanisms of intrinsic and acquired resistance to CDK4/6 inhibitors
Nikhil Wagle
Dana-Farber Cancer Institute, Newton, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Biosimilar biologic products: The US FDA perspective
Joseph Franklin
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biologic complexity: Implications for biosimilar development
Simon Hotchin
Amgen, Inc., Thousand Oaks, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biosimilar development: Clinical implications and applications
Sara A Hurvitz
UCLA, Santa Monica, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biosimilar regulatory policy: Understanding the landscape and relevance to medical practice
Sue Lim
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Introduction
Benjamin O. Anderson
University of Washington, Seattle, WA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Cancer prevention and early diagnosis: Regional issues facing for Latin-America and the Caribbean
Silvana Luciani
Pan American Health Organization, Washington, DC, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Cervical cancer prevention strategies for LMICs: How in the world do we do it?
Ophira Ginsburg
NYU Langone Health, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Colorectal cancer early diagnosis in low and middle income countries
Katherine Van Loon
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Resource-stratified guidelines and phased implementation: Where the rubber hits the road in LMICs
Benjamin O. Anderson
University of Washington, Seattle, WA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Translational control of cancer via the mRNA 5’-cap binding complex, eIF4F
Nahum Sonenberg
McGill Univ., Montreal, QC, Canada
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
<< first | < prev page: of 35 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 32 33 34 35 presentations: 1 to 25 of 866